Tag Archives: DART-AD

A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)


Clive Ballard1*, Marisa Margallo Lana2, Megan Theodoulou3, Simon Douglas4, Rupert McShane5, Robin Jacoby3, Katja Kossakowski1, Ly-Mee Yu6, Edmund Juszczak6, on behalf of the Investigators DART AD 1 Wolfson Centre for Age-Related Diseases, King’s College London, London, United Kingdom, 2 Northgate … Continue reading

Posted in PLoS Medicine, psiquiatria | Tagged , , , , , | 3 Comments